Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent
Michael Xiang(University of California, Los Angeles), David A. Frank(Brigham and Women's Hospital)
Cited by 113
Related Papers
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
|Journal of Clinical Investigation|2011|928
Signal Transducer and Activator of Transcription 3 Is Required for the Oncogenic Effects of Non–Small-Cell Lung Cancer–Associated Mutations of the Epidermal Growth Factor Receptor
|Cancer Research|2006|239
<i>KEAP1/NFE2L2</i> Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition
|Cancer Discovery|2020|172
STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-κB to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes
|Science Signaling|2014|166
JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
|Cancer Research|2022|101